<DOC>
	<DOCNO>NCT00897494</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood patient cancer laboratory may help doctor learn change may occur DNA identify biomarkers related cancer . PURPOSE : This laboratory study examine blood sample patient cancer identify biomarkers may help early detection pancreatic cancer .</brief_summary>
	<brief_title>Identification Biomarkers Early Detection Pancreatic Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Identify specific proteins interest evaluate potential role marker pancreatic cancer . - Analyze serum proteins directly mass spectrometry identify new biomarkers pancreatic cancer use early diagnosis . OUTLINE : Blood patient collect prior treatment . Plasma proteins analyze matrix-assisted laser desorption ionization time-of-flight mass spectrometry ( MALDI-TOF/MS ) and/or electrospray mass spectrometry ( ESI/MS ) . PROJECTED ACCRUAL : A total 120 patient accrue study .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis pancreatic cancer Newly diagnose disease Planning undergo surgery treatment pancreatic cancer Karmanos Cancer Institute affiliate PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>stage I pancreatic cancer</keyword>
	<keyword>stage II pancreatic cancer</keyword>
	<keyword>stage III pancreatic cancer</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
</DOC>